Literature DB >> 21576089

ΔNp63 versatilely regulates a Broad NF-κB gene program and promotes squamous epithelial proliferation, migration, and inflammation.

Xinping Yang1, Hai Lu, Bin Yan, Rose-Anne Romano, Yansong Bian, Jay Friedman, Praveen Duggal, Clint Allen, Ryan Chuang, Reza Ehsanian, Han Si, Satrajit Sinha, Carter Van Waes, Zhong Chen.   

Abstract

Head and neck squamous cell carcinoma (HNSCC) and many other epithelial malignancies exhibit increased proliferation, invasion, and inflammation, concomitant with aberrant nuclear activation of TP53 and NF-κB family members ΔNp63, cRel, and RelA. However, the mechanisms of cross-talk by which these transcription factors coordinate gene expression and the malignant phenotype remain elusive. In this study, we showed that ΔNp63 regulates a cohort of genes involved in cell growth, survival, adhesion, and inflammation, which substantially overlaps with the NF-κB transcriptome. ΔNp63 with cRel and/or RelA are recruited to form novel binding complexes on p63 or NF-κB/Rel sites of multitarget gene promoters. Overexpressed ΔNp63- or TNF-α-induced NF-κB and inflammatory cytokine interleukin-8 (IL-8) reporter activation depended on RelA/cRel regulatory binding sites. Depletion of RelA or ΔNp63 by small interfering RNA (siRNA) significantly inhibited NF-κB-specific, or TNF-α-induced IL-8 reporter activation. ΔNp63 siRNA significantly inhibited proliferation, survival, and migration by HNSCC cells in vitro. Consistent with these data, an increase in nuclear ΔNp63, accompanied by increased proliferation (Ki-67) and adhesion (β4 integrin) markers, and induced inflammatory cell infiltration was observed throughout HNSCC specimens, when compared with the basilar pattern of protein expression and minimal inflammation seen in nonmalignant mucosa. Furthermore, overexpression of ΔNp63α in squamous epithelial cells in transgenic mice leads to increased suprabasilar cRel, Ki-67, and cytokine expression, together with epidermal hyperplasia and diffuse inflammation, similar to HNSCC. Our study reveals ΔNp63 as a master transcription factor that, in coordination with NF-κB/Rels, orchestrates a broad gene program promoting epidermal hyperplasia, inflammation, and the malignant phenotype of HNSCC. ©2011 AACR

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21576089      PMCID: PMC3443863          DOI: 10.1158/0008-5472.CAN-10-3445

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  48 in total

1.  CK2 modulation of NF-kappaB, TP53, and the malignant phenotype in head and neck cancer by anti-CK2 oligonucleotides in vitro or in vivo via sub-50-nm nanocapsules.

Authors:  Matthew S Brown; Oumou T Diallo; Michael Hu; Reza Ehsanian; Xinping Yang; Pattatheyil Arun; Hai Lu; Vicci Korman; Gretchen Unger; Khalil Ahmed; Carter Van Waes; Zhong Chen
Journal:  Clin Cancer Res       Date:  2010-04-06       Impact factor: 12.531

2.  Relationships between p63 binding, DNA sequence, transcription activity, and biological function in human cells.

Authors:  Annie Yang; Zhou Zhu; Philipp Kapranov; Frank McKeon; George M Church; Thomas R Gingeras; Kevin Struhl
Journal:  Mol Cell       Date:  2006-11-17       Impact factor: 17.970

3.  Rel homology domain-containing transcription factors in the cnidarian Nematostella vectensis.

Authors:  James C Sullivan; Demetrios Kalaitzidis; Thomas D Gilmore; John R Finnerty
Journal:  Dev Genes Evol       Date:  2006-11-21       Impact factor: 0.900

4.  p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis.

Authors:  James W Rocco; Chee-Onn Leong; Nicolas Kuperwasser; Maurice Phillip DeYoung; Leif W Ellisen
Journal:  Cancer Cell       Date:  2006-01       Impact factor: 31.743

5.  p63 regulates an adhesion programme and cell survival in epithelial cells.

Authors:  Danielle K Carroll; Jason S Carroll; Chee-Onn Leong; Fang Cheng; Myles Brown; Alea A Mills; Joan S Brugge; Leif W Ellisen
Journal:  Nat Cell Biol       Date:  2006-05-21       Impact factor: 28.824

Review 6.  Nuclear factor-kappaB in cancer development and progression.

Authors:  Michael Karin
Journal:  Nature       Date:  2006-05-25       Impact factor: 49.962

7.  Cross-talks in the p53 family: deltaNp63 is an anti-apoptotic target for deltaNp73alpha and p53 gain-of-function mutants.

Authors:  Mauro Lanza; Barbara Marinari; Marina Papoutsaki; Maria Laura Giustizieri; Yuri D'Alessandra; Sergio Chimenti; Luisa Guerrini; Antonio Costanzo
Journal:  Cell Cycle       Date:  2006-09-01       Impact factor: 4.534

8.  Endogenous p63 acts as a survival factor for tumour cells of SCCHN origin.

Authors:  Niklas Thurfjell; Philip J Coates; Borek Vojtesek; Parvis Benham-Motlagh; Michael Eisold; Karin Nylander
Journal:  Int J Mol Med       Date:  2005-12       Impact factor: 4.101

9.  Hepatocyte growth factor/scatter factor differentially regulates expression of proangiogenic factors through Egr-1 in head and neck squamous cell carcinoma.

Authors:  Brian Worden; Xin Ping Yang; Tin Lap Lee; Lorena Bagain; Ning T Yeh; Joshua G Cohen; Carter Van Waes; Zhong Chen
Journal:  Cancer Res       Date:  2005-08-15       Impact factor: 12.701

10.  Identification of new p63 targets in human keratinocytes.

Authors:  Barbara Testoni; Serena Borrelli; Elena Tenedini; Daniela Alotto; Carlotta Castagnoli; Stefano Piccolo; Enrico Tagliafico; Sergio Ferrari; M Alessandra Viganò; Roberto Mantovani
Journal:  Cell Cycle       Date:  2006-12-01       Impact factor: 4.534

View more
  71 in total

1.  TNF-α promotes c-REL/ΔNp63α interaction and TAp73 dissociation from key genes that mediate growth arrest and apoptosis in head and neck cancer.

Authors:  Hai Lu; Xinping Yang; Praveen Duggal; Clint T Allen; Bin Yan; Jonah Cohen; Liesl Nottingham; Rose-Anne Romano; Satrajit Sinha; Kathryn E King; Wendy C Weinberg; Zhong Chen; Carter Van Waes
Journal:  Cancer Res       Date:  2011-09-20       Impact factor: 12.701

Review 2.  Personalized and targeted therapy of esophageal squamous cell carcinoma: an update.

Authors:  Yongjing Liu; Zhaohui Xiong; Andrea Beasley; Thomas D'Amico; Xiaoxin Luke Chen
Journal:  Ann N Y Acad Sci       Date:  2016-07-11       Impact factor: 5.691

Review 3.  The pivotal role of pathology in the management of lung cancer.

Authors:  Morgan R Davidson; Adi F Gazdar; Belinda E Clarke
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

4.  ACTL6A Is Co-Amplified with p63 in Squamous Cell Carcinoma to Drive YAP Activation, Regenerative Proliferation, and Poor Prognosis.

Authors:  Srinivas Vinod Saladi; Kenneth Ross; Mihriban Karaayvaz; Purushothama R Tata; Hongmei Mou; Jayaraj Rajagopal; Sridhar Ramaswamy; Leif W Ellisen
Journal:  Cancer Cell       Date:  2016-12-29       Impact factor: 31.743

5.  Blockage of the NLRP3 inflammasome by MCC950 improves anti-tumor immune responses in head and neck squamous cell carcinoma.

Authors:  Lei Chen; Cong-Fa Huang; Yi-Cun Li; Wei-Wei Deng; Liang Mao; Lei Wu; Wen-Feng Zhang; Lu Zhang; Zhi-Jun Sun
Journal:  Cell Mol Life Sci       Date:  2017-11-28       Impact factor: 9.261

6.  PKK deletion in basal keratinocytes promotes tumorigenesis after chemical carcinogenesis.

Authors:  Luojing Chen; Matthew S Hayden; Elaine S Gilmore; Carolina Alexander-Savino; David Oleksyn; Kathleen Gillespie; Jiyong Zhao; Brian Poligone
Journal:  Carcinogenesis       Date:  2018-03-08       Impact factor: 4.944

7.  Expression of p53 family genes in urinary bladder cancer: correlation with disease aggressiveness and recurrence.

Authors:  Danae Papadogianni; Nikolaos Soulitzis; Demetrios Delakas; Demetrios A Spandidos
Journal:  Tumour Biol       Date:  2013-11-11

8.  Lymphotoxin-β receptor-NIK signaling induces alternative RELB/NF-κB2 activation to promote metastatic gene expression and cell migration in head and neck cancer.

Authors:  Rita Das; Jamie Coupar; Paul E Clavijo; Anthony Saleh; Tsu-Fan Cheng; Xinping Yang; Jianhong Chen; Carter Van Waes; Zhong Chen
Journal:  Mol Carcinog       Date:  2018-11-28       Impact factor: 4.784

9.  A MicroRNA196a2* and TP63 circuit regulated by estrogen receptor-α and ERK2 that controls breast cancer proliferation and invasiveness properties.

Authors:  Kyuri Kim; Zeynep Madak-Erdogan; Rosa Ventrella; Benita S Katzenellenbogen
Journal:  Horm Cancer       Date:  2012-12-19       Impact factor: 3.869

10.  Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers.

Authors:  Curtis R Pickering; Jiexin Zhang; Suk Young Yoo; Linnea Bengtsson; Shhyam Moorthy; David M Neskey; Mei Zhao; Marcus V Ortega Alves; Kyle Chang; Jennifer Drummond; Elsa Cortez; Tong-Xin Xie; Di Zhang; Woonbok Chung; Jean-Pierre J Issa; Patrick A Zweidler-McKay; Xifeng Wu; Adel K El-Naggar; John N Weinstein; Jing Wang; Donna M Muzny; Richard A Gibbs; David A Wheeler; Jeffrey N Myers; Mitchell J Frederick
Journal:  Cancer Discov       Date:  2013-04-25       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.